European Union: Commission zeroes in on innovation in merger control and pay-for-delay cases
Competition authorities in Europe, particularly the European Commission (the Commission), have historically been very active in enforcement in the life sciences industry. This trend is expected to continue, as confirmed by the Commission’s recent report on …